My Companies
Notification
Account
Log Out
Login
Board approved up to Rs900 crore rights issue of partly paid-up Rs5 shares to eligible shareholders, set up rights committee and approved postal ballot notice, and launched Evonile Pharma website. Context: clarifies Minipress debt refinancing awaited since September.
Evonile Pharma Board Approves ₹900 Crore Partly Paid Rights Issue
Novartis India Acquires Minipress Rights For ₹1,250 Crore
Novartis India Signs ₹10 Crore Exclusive Agreement For Retina Portfolio
Novartis India Approves ₹1,250 Crore Minipress Acquisition From Pfizer
Novartis India Terminates Dr Reddy’s Exclusive Distribution Agreement